Spain / Grifols looks to Egypt; New Leadership Generation at Almirall; Ferrer’s EIB Loan; Esteve’s European Expansion
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.
Contact Info
Biogen Idec Iberia, S.L.
Paseo de la Castellana 41 – 3a
28046 Madrid
Spain
Phone: +34 91 310 71 10
Fax: +34 91 310 71 11
www.biogenidec.es
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest…
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat…
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences…
Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand…
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape,…
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be…
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no…
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia…
Perhaps the only CEO of a dermo-cosmetics company with a PhD in astrophysics and space technology as well as three…
The North-Eastern region of Catalonia is one of Spain’s most prosperous and has been allocating increasingly…
Rocco De Bernardis, managing director for Johnson & Johnson Medical Devices in Spain offers his insights into…